Haemostasis and beyond: The expanding role of desmopressin in intensive care
Saketh Vinjamuri, Ekta Tiwari, Sahil Kataria, Deven Juneja · 2025
Read Haemostasis and beyond: The expanding role of desmopressin in intensive care by Saketh Vinjamuri, Ekta Tiwari, Sahil Kataria, Deven Juneja (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12687054.txt.
Description
Saketh Vinjamuri, Ekta Tiwari, Sahil Kataria, and Deven Juneja review the growing uses of a hormone based drug in intensive care, in a paper from 2025. The drug, desmopressin, copies a natural hormone that tells the kidneys to hold water. It also prompts the release of two clotting factors, which made it a treatment for mild bleeding disorders.
The drug was built in the late nineteen sixties and entered clinic use in the early seventies for a water balance disease. Its clotting effect was spotted later and widened its role. With little squeezing effect on blood vessels, it is gentler on the heart than the natural hormone. The review traces how intensive care teams now use it past bleeding, and weighs where the proof is strong or still thin.
Catalog record
| CREATOR | Saketh Vinjamuri, Ekta Tiwari, Sahil Kataria, Deven Juneja |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |